Quo vadis, neutrophil?
- PMID: 35245478
- DOI: 10.1016/j.cell.2022.02.009
Quo vadis, neutrophil?
Abstract
Neutrophil recruitment from blood into tissues is a hallmark of inflammation and anti-microbial host defense. In this issue, De Giovanni et al. describe an unanticipated role for a serotonin metabolite, 5-HIAA, which is produced by activated platelets and mast cells and engages the orphan receptor, GPR35, to recruit neutrophils to inflamed tissues.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests Ulrich H. von Andrian is a founder of Selecta Biosciences and of Monopteros Biotherapeutics and a member of both companies’ scientific advisory boards. He is also a member of the scientific advisory boards of Avenge Bio, Beam Therapeutics, Bluesphere Bio, Cygnal, Evelo, Intergalactic, Interon, Mallinckrodt Pharmaceutical, Moderna, Morphic Therapeutics, Rubius, and SQZ.
Comment on
-
GPR35 promotes neutrophil recruitment in response to serotonin metabolite 5-HIAA.Cell. 2022 Mar 3;185(5):815-830.e19. doi: 10.1016/j.cell.2022.01.010. Epub 2022 Feb 10. Cell. 2022. PMID: 35148838 Free PMC article.